Pharma Pulse 5/9/24: Officials Release Draft Legislation Aimed at Prescription Drug Shortage Issues, Assessing LP-284 ...
Assessing LP-284 with RADR for NHL and Other Targeted Cancers In this Pharmaceutical Executive video interview, Panna Sharma, CEO, Lantern Pharma, explains which specific endpoints they'll be looking at in the Phase I trial to assess LP-284's …